In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
Resmed Inc (NYSE: RMD) closed the day trading at $269.21 down -0.66% from the previous closing price of $270.99. In other words, the price has decreased by -$0.66 from its previous closing price. On the day, 1.8 million shares were traded. RMD stock price reached its highest trading level at $270.49 during the session, while it also had its lowest trading level at $265.49.
Ratios:
For a better understanding of RMD, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 32.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 23.72. For the most recent quarter (mrq), Quick Ratio is recorded 2.53 and its Current Ratio is at 3.44. In the meantime, Its Debt-to-Equity ratio is 0.14 whereas as Long-Term Debt/Eq ratio is at 0.14.
On July 15, 2025, RBC Capital Mkts Upgraded its rating to Outperform which previously was Sector Perform but kept the price unchanged to $294.
On March 19, 2025, Morgan Stanley started tracking the stock assigning a Overweight rating and target price of $280.Morgan Stanley initiated its Overweight rating on March 19, 2025, with a $280 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 02 ’25 when Sandercock Brett sold 3,000 shares for $270.77 per share. The transaction valued at 812,310 led to the insider holds 87,745 shares of the business.
Sandercock Brett bought 3,000 shares of RMD for $812,310 on Sep 02 ’25. On Aug 18 ’25, another insider, Hernandez John, who serves as the Director of the company, sold 2,575 shares for $287.10 each. As a result, the insider received 739,289 and left with 4,045 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RMD now has a Market Capitalization of 39416381440 and an Enterprise Value of 39058702336. As of this moment, Resmed’s Price-to-Earnings (P/E) ratio for their current fiscal year is 28.31, and their Forward P/E ratio for the next fiscal year is 22.32. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.66 while its Price-to-Book (P/B) ratio in mrq is 6.60. Its current Enterprise Value per Revenue stands at 7.59 whereas that against EBITDA is 20.995.
Stock Price History:
The Beta on a monthly basis for RMD is 0.84, which has changed by 0.099803925 over the last 52 weeks, in comparison to a change of 0.1716845 over the same period for the S&P500. Over the past 52 weeks, RMD has reached a high of $293.81, while it has fallen to a 52-week low of $199.92. The 50-Day Moving Average of the stock is -0.82%, while the 200-Day Moving Average is calculated to be 9.89%.
Shares Statistics:
Over the past 3-months, RMD traded about 937.00K shares per day on average, while over the past 10 days, RMD traded about 1055480 shares per day. A total of 146.39M shares are outstanding, with a floating share count of 145.50M. Insiders hold about 0.63% of the company’s shares, while institutions hold 65.36% stake in the company. Shares short for RMD as of 1755216000 were 8937310 with a Short Ratio of 9.54, compared to 1752537600 on 9377215. Therefore, it implies a Short% of Shares Outstanding of 8937310 and a Short% of Float of 7.0199996.
Dividends & Splits
RMD’s forward annual dividend rate is 2.19, up from 2.12 a year ago. Against a Trailing Annual Dividend Yield of 0.007823166The stock’s 5-year Average Dividend Yield is 0.82. The current Payout Ratio is 22.30% for RMD, which recently paid a dividend on 2025-08-14 with an ex-dividend date of 2025-08-14. Stock splits for the company last occurred on 2010-08-31 when the company split stock in a 2:1 ratio.
